Martin Salzmann

1.9k citations
19 papers · 217 indexed · h-index 8
Topics
Cancer Immunotherapy and Biomarkers (7 papers)Brain Metastases and Treatment (4 papers)CAR-T cell therapy research (3 papers)
Partner nations
GermanyFrance

In The Last Decade

Martin Salzmann

19 papers receiving 211 citations

Peers

Martin Salzmann
Comparison fields: 5 of 53
  • Oncology 113
  • Epidemiology 61
  • Neurology 41
  • Molecular Biology 35
  • Immunology 35
Replace Natalia Castrejón de Anta with:
Natalia Castrejón de Anta Spain
Lourdes Martín‐Martín Spain
Lavinia Grapulin Italy
Noah Graham United States
Tetiana Skrypets Italy
Virginia Mancini Italy
Marianna Sassone Italy
Marylee M. Kott United States
Anke Krause Germany
Nadia Bianco Italy
Martin Salzmann relative to Natalia Castrejón de Anta Spain Natalia Castrejón de Anta's profile →
Citations per field
00.5×2.7×
Natalia Castrejón de Anta · 1×
Citations per year

Countries citing papers authored by Martin Salzmann

Since Specialization
Citations

This map shows the geographic impact of Martin Salzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Salzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Salzmann more than expected).

Fields of papers citing papers by Martin Salzmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Salzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Salzmann. The network helps show where Martin Salzmann may publish in the future.

Co-authorship network of co-authors of Martin Salzmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Salzmann. A scholar is included among the top collaborators of Martin Salzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Salzmann. Martin Salzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 7
2 2
3 1
4 11
5 3
6 1
7 19
8 35
9 3
10 2
11 1
12 3
13 47
14 15
15 22
16 2
17 5
18 31
19 7

About Martin Salzmann

Martin Salzmann is a scholar working on Oncology, Immunology and Allergy and Dermatology, having authored 19 papers that have together received 217 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Brain Metastases and Treatment (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (113 citations), Dermatology (34 citations) and Neurology (41 citations). Martin Salzmann has collaborated with scholars based in Germany and France. Frequent co-authors include Jessica C. Hassel, Alexander Enk, Y Bascoulergue, Jacques Guyotat, Philippe Bret, Frederik Marmé, Selma Ugurel, Carmen Loquai, Lisa Zimmer and Ulrike Leiter. Their work appears in journals such as Journal of Clinical Oncology, Neurosurgery and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026